Krka Boss Says 2004 Profit Up 20%, No Takeover in Sight
Novo Mesto, 22 December - Pharmaceutical group Krka expects to finish the year with revenues of SIT 113bn (EUR 471.3m), which is 15 percent more than last year, incoming Krka chairman Joze Colaric has told the press.
The rest of this news item is available to subscribers.
The news item consists of 1.167 characters (without spaces) or 245 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.